Suppr超能文献

血液透析与血液透析滤过期间心肌灌注的比较。

Comparison of myocardial perfusion during hemodialysis and hemodiafiltration.

作者信息

De Andrade Roger, Kotze Tessa, Lesosky Maia, Swanepoel Charles

机构信息

Division of Nephrology and Hypertension, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

出版信息

Nephron Clin Pract. 2014;126(3):151-8. doi: 10.1159/000360907. Epub 2014 Apr 24.

Abstract

BACKGROUND

We compared myocardial perfusion in patients first on conventional hemodialysis (HD) and then on hemodiafiltration (HDF).

METHODS

Myocardial perfusion scintigraphy was performed in 25 patients pre- and post-HD. Patients were then converted to HDF for 3 months prior to repeating the scintigraphy. (99m)Tc-methoxyisobutylisonitrile was administered intravenously pre-dialysis and then within the last hour of dialysis. Up to 90 min after injection, tomographic images were obtained. Clinical and laboratory data were collected pre- and post-dialysis.

RESULTS

Five patients did not complete the study. Patients entering the study were on average 41.7 years old and on HD for 4 years (median). The mean standard Kt/V for the two procedures was not statistically different (1.55 for HD and 1.48 for HDF). The mean substitution volume for HDF was 18.48 liters. There were no significant differences in changes in blood pressures between HD and HDF (p = 0.22). There were no significant differences in myocardial perfusion defects in patients on HD compared with those on HDF. During dialysis in both studies, the data showed a general trend to worsening of perfusion defects.

CONCLUSIONS

There was no advantage of HDF over HD with no statistical difference in perfusion defects between HD and HDF. There was a trend to worsening of perfusion defects during dialysis in the majority on HD and HDF. Midweek dialysis perfusion scores appeared to be consistently lower than early-week dialysis, but this was not statistically significant. The pathogenesis of the defects may lie at a microcirculatory level.

摘要

背景

我们比较了患者先进行常规血液透析(HD)然后进行血液透析滤过(HDF)时的心肌灌注情况。

方法

对25例患者在HD前后进行心肌灌注闪烁显像。然后患者转为HDF治疗3个月,之后重复闪烁显像。在透析前静脉注射(99m)锝-甲氧基异丁基异腈,然后在透析的最后一小时内再次注射。注射后长达90分钟,获取断层图像。收集透析前后的临床和实验室数据。

结果

5例患者未完成研究。进入研究的患者平均年龄为41.7岁,接受HD治疗4年(中位数)。两种治疗方法的平均标准Kt/V无统计学差异(HD为1.55,HDF为1.48)。HDF的平均置换量为18.48升。HD和HDF之间的血压变化无显著差异(p = 0.22)。HD患者与HDF患者的心肌灌注缺损无显著差异。在两项研究的透析过程中,数据显示灌注缺损总体上有恶化趋势。

结论

HDF并不优于HD,HD和HDF之间的灌注缺损无统计学差异。大多数接受HD和HDF治疗的患者在透析过程中灌注缺损有恶化趋势。周中透析的灌注评分似乎始终低于周初透析,但这无统计学意义。缺损的发病机制可能在于微循环水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验